MDMA: GPOs Should Be Included in "Sunshine" Provisions

In commentary issued to CMS, the Medical Device Manufacturers Association has restated their stance that payments to group purchasing organizations should be covered under "sunshine" provisions for transparency and competition purposes.

Thomas Novelli, MDMA vice president of government relations, believes the same rationale behind the Physician Payment Sunshine provision of the Patient Protection and Affordable Care Act should be applied to the GPO-manufacturer relationships. MDMA's recommendations include reporting of medical device companies' payments to GPOs, clear definitions of categories of payment to minimize repetitive reporting and use of a spreadsheet to report data to CMA.

"MDMA strongly believes that providing enhanced transparency within the manufacturer-GPO relationship will benefit all stakeholders," Mr. Novelli said.

Read MDMA's letter to CMS about GPO reporting.

Read other coverage about MDMA:

- MDMA Announces Support of Legislation to Strengthen the Research & Development Tax Credit

MDMA Applauds Bills to Repeal Medical Device Tax

MDMA Expresses Concern Over 'Parallel Review' Process Proposal

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers